Cannabis Biotech In Talks With Research Chemist to Explore Transmucosal Delivery

FLORIDA: Puget Technologies announced its subsidiary, Cannabis Biotech, is in talks with a research chemist to explore the development of an exclusive cannabis-based metered-dose transmucosal delivery platform. The transmucosal system is an effective means to introduce treatments across the mucous membrane and is a well-established and accepted system of administration. Cannabis Biotech sought out this eminently qualified professional in the beginning stages as it enters the multi-billion dollar medical marijuana industry with a commitment to maintaining strict protocols and quality standards. [Read more…]